Postnatal Corticosteroids Policy for Very Preterm Infants and Bronchopulmonary Dysplasia

Introduction: Postnatal corticosteroids (PNC) are effective for reducing bronchopulmonary dysplasia (BPD) in very preterm neonates but are associated with adverse effects including an increased risk of cerebral palsy. PNC use in Europe is heterogeneous across regions. This study aimed to assess whet...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neonatology (Basel, Switzerland) Switzerland), 2020-11, Vol.117 (3), p.308-315
Hauptverfasser:	Nuytten, Alexandra, Behal, Hélène, Duhamel, Alain, Jarreau, Pierre-Henri, Torchin, Heloïse, Milligan, David, Maier, Rolf F., Zemlin, Michael, Zeitlin, Jennifer, Truffert, Patrick
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - adverse effects Analysis Bronchopulmonary dysplasia Bronchopulmonary Dysplasia - epidemiology Corticosteroids Gestational Age Health aspects Humans Infant Infant, Newborn Infant, Premature Infant, Very Low Birth Weight Infants Infants (Premature) Life Sciences Neonatal intensive care Original Paper Patient outcomes Policy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!